City University of New York (CUNY)

CUNY Academic Works
Publications and Research

City College of New York

2015

DNA Methylation Dynamics of Germinal Center B Cells Are
Mediated by AID
Pilar M. Dominguez
Weill Cornell Medical College

Matt Teater
Weill Cornell Medical College

Nyasha Chambwe
Weill Cornell Medical College

Matthias Kormaksson
IBM Research

David Redmon
Weill Cornell Medical College

See next page for additional authors

How does access to this work benefit you? Let us know!
More information about this work at: https://academicworks.cuny.edu/cc_pubs/642
Discover additional works at: https://academicworks.cuny.edu
This work is made publicly available by the City University of New York (CUNY).
Contact: AcademicWorks@cuny.edu

Authors
Pilar M. Dominguez, Matt Teater, Nyasha Chambwe, Matthias Kormaksson, David Redmon, Jennifer Ishii,
Bao Vuong, Jayanta Chaudhuri, Ari Melnick, Aparna Vasanthakumar, Lucy A. Godley, F. Nina Papavasiliou,
Oliver Elemento, and Rita Shaknovich

This article is available at CUNY Academic Works: https://academicworks.cuny.edu/cc_pubs/642

Article

DNA Methylation Dynamics of Germinal Center B
Cells Are Mediated by AID
Graphical Abstract

Authors
Pilar M. Dominguez, Matt Teater,
Nyasha Chambwe, ...,
F. Nina Papavasiliou, Olivier Elemento,
Rita Shaknovich

Correspondence
rshaknovich@gmail.com

In Brief
Dominguez et al. use mouse models to
study changes in DNA methylation in B
cells during entry into germinal centers
in vivo. They determine that site-specific
demethylation and diversification of
methylome in germinal center B cells are
dependent on AID function. AIDdependent epigenetic hotspots affect
genes important for lymphocyte
development.

Highlights
d

B cell transition through the GC is characterized by marked
loss of DNA methylation

d

B cell transition through the GC is associated with increased
methylome diversity

d

AID is essential for demethylation and diversification of
methylome in GCBs

d

AID-dependent epigenetic hotspots are located in genes
required for B cell function

Dominguez et al., 2015, Cell Reports 12, 2086–2098
September 29, 2015 ª2015 The Authors
http://dx.doi.org/10.1016/j.celrep.2015.08.036

Accession Numbers
GSE71702

Cell Reports

Article
DNA Methylation Dynamics of Germinal
Center B Cells Are Mediated by AID
Pilar M. Dominguez,1,10 Matt Teater,1,2,10 Nyasha Chambwe,2,3 Matthias Kormaksson,4 David Redmond,2,3 Jennifer Ishii,5
Bao Vuong,6 Jayanta Chaudhuri,6 Ari Melnick,1 Aparna Vasanthakumar,7 Lucy A. Godley,7 F. Nina Papavasiliou,8
Olivier Elemento,2,3,11 and Rita Shaknovich1,9,11,*
1Division

of Hematology and Oncology, Weill Cornell Medical College, New York, NY 10065, USA
for Computational Biomedicine, Weill Cornell Medical College, New York, NY 10065, USA
3Department of Physiology and Biophysics, Weill Cornell Medical College, New York, NY 10065, USA
4IBM Research, Rio de Janeiro 22290-240, Brazil
5Epigenomics Core Facility, Weill Cornell Medical College, New York, NY 10065, USA
6Immunology Program, Memorial Sloan-Kettering Cancer Center, Gerstner Sloan-Kettering Graduate School, New York, NY 10065, USA
7Department of Medicine, The University of Chicago, Chicago, IL 60637, USA
8Laboratories of Lymphocyte Biology and Molecular Parasitology, The Rockefeller University, New York, NY 10065, USA
9Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY 10065, USA
10Co-first author
11Co-senior author
*Correspondence: rshaknovich@gmail.com
http://dx.doi.org/10.1016/j.celrep.2015.08.036
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
2Institute

SUMMARY

Changes in DNA methylation are required for the formation of germinal centers (GCs), but the mechanisms of such changes are poorly understood. Activation-induced cytidine deaminase (AID) has been
recently implicated in DNA demethylation through
its deaminase activity coupled with DNA repair. We
investigated the epigenetic function of AID in vivo in
germinal center B cells (GCBs) isolated from wildtype (WT) and AID-deficient (Aicda / ) mice. We
determined that the transit of B cells through the
GC is associated with marked locus-specific loss of
methylation and increased methylation diversity,
both of which are lost in Aicda / animals. Differentially methylated cytosines (DMCs) between GCBs
and naive B cells (NBs) are enriched in genes that
are targeted for somatic hypermutation (SHM) by
AID, and these genes form networks required for
B cell development and proliferation. Finally, we
observed significant conservation of AID-dependent
epigenetic reprogramming between mouse and human B cells.
INTRODUCTION
DNA methylation is an epigenetic modification that regulates
genomic imprinting, X chromosome inactivation, and cell fates
during development (Smith and Meissner, 2013) and chromosomal stability, repression of transposable elements, and gene
expression during the lifetime of the organism (Bird, 2002; Jones
and Takai, 2001). The majority of the DNA methylation in
mammalian genomes takes place within a CpG dinucleotide

context, and 5-methyl-C has been called a fifth base in the
genome (Novik et al., 2002).
B cell development is associated with significant plasticity and
changes of the DNA methylome, occurring from lymphoid commitment of hematopoietic stem cells in the bone marrow to
peripheral B cell maturation in the secondary lymphoid organs
(Hodges et al., 2011; Ji et al., 2010; Zilbauer et al., 2013).
The transition from naı̈ve B cells (NBs) to germinal center B
cells (GCBs), critical for affinity maturation and generation of
an improved, long-lasting immune response, is accompanied
by marked demethylation of the genome and more heterogeneous DNA methylation patterning (Lai et al., 2013; Shaknovich
et al., 2011). The mechanisms of these modifications of the
methylome remain poorly understood and, therefore, we set
out to understand how these changes arise in B cells.
In contrast to DNA methylation gain, the identities of the enzymes that catalyze DNA demethylation have largely remained
elusive. Activation-induced cytidine deaminase (AID) is highly
expressed in GCBs and is necessary for the antigen-dependent
activation process by which NBs transition through the germinal center (GC) of the secondary lymphoid organs (Bunting
and Melnick, 2013; Klein and Dalla-Favera, 2008). AID converts deoxycytosines (dCs) into deoxyuracils (dUs), producing
dU:dG mismatches that are removed by both mismatch repair
and base excision repair (Honjo et al., 2005; Zan and Casali,
2013). These repair processes are required for somatic hypermutation (SHM) and class switch recombination (CSR) of immunoglobulin (Ig) genes, necessary steps of affinity maturation
within the GC (Conticello, 2008; Muramatsu et al., 2000; Zan
and Casali, 2013). Interestingly, AID function is not restricted
to Ig loci, and 25% of highly expressed genes in GCBs are targeted by AID (Liu et al., 2008). Moreover, anti-AID chromatin
immunoprecipitation (ChIP) experiments showed a genomewide recruitment of AID in ex vivo activated B cells (Yamane
et al., 2011).
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Figure 1. Loss of AID Abrogates CpG Methylation Changes during GC Transition
(A) Combined CpG methylation of NBs and GCBs from WT mice (seven replicates; left) and Aicda / mice (six replicates; right), determined by ERRBS using a
20% methylation difference threshold and FDR < 0.001, Fisher’s exact test. Hypo-DMCs are indicated in blue, and hyper-DMCs are indicated in yellow.
(B) Number of DMCs between GCBs and NBs from WT and Aicda / mice determined by ERRBS using a 20% methylation difference threshold and FDR < 0.001,
Fisher’s exact test. Hypo-DMCs are indicated in blue, and hyper-DMCs are indicated in yellow. (A) and (B) show that the DNA methylation changes after GC
transition in WT mice are abrogated in Aicda / mice.
(C) Density plot showing delta methylation values (GCB% NB%) determined by ERRBS in WT and Aicda / mice. Aicda / delta methylation values are
decreased compared to WT, indicating less changes in methylation during GC transition.
See also Figure S1.

Several studies in non-lymphoid tissues have demonstrated
that AID can also participate in loss of methylation. AID has
been implicated in DNA demethylation during zebrafish development (Rai et al., 2008), reprogramming in heterokaryons (Bhutani
et al., 2010) and pluripotent germ cells (Popp et al., 2010), and
late reprogramming of induced pluripotent stem cells in mice
(Kumar et al., 2013). The mechanism by which AID demethylates
is not completely elucidated, although it is thought to occur
via deaminase activity followed by base excision DNA repair
and replacement with unmethylated C (Klein and Dalla-Favera,
2008; Küppers, 2005).
No DNA demethylation role for AID has yet been uncovered
in vivo in B cells, although several lines of evidence point to
such function. We previously demonstrated that hypomethylated
regions in human GCBs were enriched for the putative AID binding site RGYW (Shaknovich et al., 2011) and that hypomethylation
in GCB-derived lymphomas correlated with AID expression (De
et al., 2013). Considering these observations in light of the AID demethylation role in other cell types, we examined the epigenetic
function of AID in GCBs. In this study, we establish that AID functions as an epigenetic modifier by promoting loss of DNA methylation and increasing methylation diversity during the GC stage of
B cell maturation in vivo in human and murine B cells.
RESULTS
Loss of AID Abrogates CpG Methylation Changes during
GC Transition
We previously observed significant loss of DNA methylation in
human GCBs (Lai et al., 2013; Shaknovich et al., 2011). We hy-

pothesized that AID would be at least partly responsible for this
decrease. To investigate the role of AID in the genome-wide
methylation changes occurring during NB to GCB transition,
we induced T cell-dependent GC formation with 4-NP-chicken
gamma globulin (NP-CGG) in wild-type (WT) (seven replicates)
and Aicda / (six replicates) mice. Mice were sacrificed at day
10 post-injection, and splenic NBs (B220+GL7 CD95 ) and
GCBs (B220+GL7+CD95+) were isolated. To profile the methylome of NBs and GCBs, we performed enhanced reduced representation sequencing (ERRBS), an efficient single-nucleotide
resolution high-throughput technique that interrogates 2–4 million distinct CpGs (Akalin et al., 2012). Upon rigorous quality
control of bisulfite conversion (>99.5% in all samples) and read
mapping frequency (>70%), we called differentially methylated
CpGs (DMCs) between NBs and GCBs using a combination of
statistical difference (false discovery rate [FDR] < 0.001 using
Fisher’s exact test) and methylation level difference greater
than 20% (see Experimental Procedures). We observed that
NB to GCB transition in WT mice was accompanied by significant
changes in DNA methylation, including 8,308 hypomethylated
DMCs (hypo-DMCs) and 3,390 hypermethylated DMCs (hyperDMCs) (Figures 1A and 1B). These changes were independent
of class-switched B cell receptors, since unswitched (IgM+)
GCBs and total GCBs presented similar patterns of methylation
(data not shown). This is consistent with our previous results
showing a genome-wide loss of methylation in primary human
GCB samples compared to NBs (Shaknovich et al., 2011). On
the contrary, our profiling of Aicda / animals resulted in minimal
observed changes in DNA methylation during the transition from
NBs to GCBs: only 703 of CpGs revealed hypomethylation and
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Figure 2. AID Contributes to Epigenetic Diversity within GCB

(A and B) Heatmap (A) and density plot (B) showing the intra-group pairwise methylation distance between ERRBS profiles of NB and GCB replicates from WT and
Aicda / mice. WT GCBs have greater pairwise distance than WT NBs, indicating increased diversity among methylation profiles. On the contrary, Aicda / GCB
replicates have lower pairwise distance than their WT counterparts, closer to Aicda / NB samples.
(C) Density plot comparing pairwise methylation distance between NBs and GCBs from WT and Aicda / mice. NB to GCB transition in Aicda / mice is
associated with lower pairwise distance than in WT mice, indicating less diversity between Aicda / NB and GCB profiles.
(D) CpG methylation variance from MassARRAY data. The histogram shows the difference in variance between WT and Aicda / mice (varDWT varDAicda / ),
with varD being the log-fold change in methylation variance during NB to GCB transition in WT or Aicda / cells. Variance in WT animals is statistically greater than
in AID-deficient animals (positive values).
See also Figures S2 and S3.

172 CpGs revealed hypermethylation (Figures 1A and 1B). We
also found that Aicda / mice had reduced global methylation
differences during the NB to GCB transition, indicating that loss
of AID also resulted in less methylome plasticity at non-differentially methylated CpGs (Figure 1C). This occurred despite comparable ERRBS coverage in WT and Aicda / cells and similar
global methylation levels, as measured using liquid chromatography-mass spectrometry (LC-MS), in NBs from WT and
Aicda / mice (Figure S1). LC-MS analysis also revealed higher
genome-wide levels of 5mC in Aicda / GCBs compared to
WT GCBs (Figure S1). Our results indicate that AID is responsible
for the majority of the methylome changes that B cells undergo
during their transit through the GC.

AID Contributes to Epigenetic Diversity within GCBs
We hypothesized that AID might also be responsible for the
previously described increased methylation diversity in GCBs
compared to NBs (De et al., 2013). To that end, we evaluated
the epigenetic diversity within the NB group and GCB group
from WT and Aicda / mice, calculating all pairwise distances
between ERRBS profiles (see Experimental Procedures). We
found that WT GCB replicates had greater pairwise methylation
distance to each other than WT NB samples had to each other,
corresponding to higher average methylation diversity (Figures
2A and 2B; NB WT:GCB WT, Wilcoxon p = 4.5e-09). This is
consistent with epigenetic diversification of B cells during their
passage through the GC. Importantly, Aicda / GCB replicates
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displayed significantly lower intra-group methylation distance
than WT GCB replicates (Figures 2A and 2B; GCB WT:GCB
Aicda / , Wilcoxon p = 3.59e-10), indicating that loss of AID
results in a more homogenous GCB methylome, closer to
the methylome of Aicda / NBs (Figures 2A and 2B; NB
Aicda / :GCB Aicda / , Wilcoxon p = 0.000323). We also found
lower pairwise methylation distance during transition from
Aicda / NBs to GCBs than from WT NBs to GCBs (Figure 2C;
Wilcoxon p = 1.76e-20). This decreased diversity is consistent
with the abrogation of methylation changes during the NB
to GCB transition observed in AID-deficient mice (see Figure 1C).
To further validate these findings, we utilized an orthogonal
DNA methylation quantification approach based on Sequenom’s MassARRAY Epityper, which detects the mass difference between methylated and unmethylated CpGs using
matrix-assisted laser desorption/ionization time-of-flight mass
spectrometry. We performed MassARRAY on ten randomly
selected genomic loci spanning 30 kb in three replicate pairs
of NBs and GCBs from WT and Aicda / mice. We then calculated log-fold change in methylation variance to determine
whether methylation diversity increased during the NB to GCB
transition in WT (varDWT) and Aicda / cells (varDAicda / ).
Most studied CpGs had greater methylation variance augmentation in WT as compared to Aicda / cells (positive values)
during GC transition (Figures 2D and S2). These results altogether strongly suggest that, in addition to its established role
in SHM and CSR, AID contributes to the diversification of DNA
methylation in the GCB genome.
Previous experiments with AID depletion within an ex vivo
system showed no methylation changes (Fritz et al., 2013).
In order to reconcile our in vivo AID-dependent methylation
changes with these earlier observations, we activated CD43
splenic WT cells (NB) in the presence of lipopolysaccharide
(LPS), interleukin-4 (IL-4), and anti-CD40 and infected them
with either empty vector (EV) or a vector expressing the fulllength Aicda cDNA (AID). We confirmed by qPCR and western
blot that the AID-overexpressing cells expressed higher
levels of AID than EV-infected cells (Figure S3A). Moreover,
we detected a higher percentage of class-switched splenocytes when AID was overexpressed (Figures S3B and S3C).
We performed ERRBS profiling on sorted GFP+IgG1+ cells
(class-switched infected cells) and observed few differences
in methylation between AID-overexpressing and EV-infected
B cells, with less than 1,000 hyper- and hypo-DMCs (Figure S3D). We also calculated the pairwise methylation distance
and found a high degree of homogeneity among all sample
ERRBS profiles, suggesting that methylation diversity between
AID-overexpressing and EV-infected B cells was similar and
comparable to NB diversity (Figure S3E). These results support
the previous findings obtained by Fritz et al. (Fritz et al., 2013).
The ex vivo stimulated B cells differ from GCBs in that they
present significantly reduced levels of SHM—predominantly
targeting the Sm region—compared to GCBs induced in vivo
(Liu et al., 2008; McKean et al., 1984; Robbiani et al., 2009).
A reduced rate of SHM and the absence of methylome modifications in ex vivo activated B cells support the hypothesis of
convergence of the mechanisms for SHM and methylome
editing.

Methylation Changes in Aicda / GCBs Are Not Due to
Changes in the Cellular Composition or Clonality within
the GC
In order to rule out the possibility that abrogation of methylation
changes in Aicda / GCBs arises due to changes in the cellular
composition within the GC (content of centroblasts [CBs] versus
centrocytes [CCs]) or clonal diversity, we carried out detailed
analysis of GCBs from WT and Aicda / animals. Flow cytometry
analysis of the spleen confirmed hyperplasia of the GC in
Aicda / mice (Figure S3F), in agreement with previous reports
(Muramatsu et al., 2000; Robbiani et al., 2009). Both WT and
Aicda / animals had the same proportion of CB (CXCR4high)
and CC (CXCR4low) within the GC (Figure S3G). To confirm this
result, we performed RNA sequencing (RNA-seq) on GCBs isolated from WT and Aicda / mice and compared their expression profiles for the genes that constitute the CB (dark zone
[DZ]) and CC (light zone [LZ]) signatures, identified by Victora
et al. (Victora et al., 2010) (Figure S3H). The expression for these
CB- and CC-specific genes was highly correlated between WT
and Aicda / cells (Pearson correlation coefficient = 0.984 for
DZ genes and 0.989 for LZ genes), indicating that both genotypes had comparable gene expression profiles. In addition,
we investigated whether there were any differences in clonal
complexity in the GC between WT and Aicda / mice. For that
purpose, we amplified rearranged IgH, Igk, and Igl regions using
primers capturing the most abundant families of Ig rearrangements (Chang et al., 1992; Cobaleda et al., 2007; Schlissel
et al., 1991) and performed high-throughput sequencing using
the Illumina MiSeq (PE2x150). Statistical analysis of the Ig rearrangements (see Experimental Procedures) revealed no significant difference in clonal complexity and or composition of VH
regions between WT GCBs and Aicda / GCBs (p = 0.8571,
Wilcoxon rank sum test) (Figure S3I). Altogether, these findings
indicate that the composition and the clonality of WT and AIDdeficient GCBs are equivalent.
AID-Dependent Hypo-DMCs Are Enriched at SHM
Hotspot Genes and dsDNA Breaks
To investigate the genomic distribution of AID-dependent methylation changes, we defined AID-dependent hypo- and hyperDMCs as CpGs that are hypomethylated (blue rectangle, Figure 3A) or hypermethylated (yellow rectangle, Figure 3A) during
NB to GCB transition in WT animals but show no respective differential methylation changes in Aicda / animals. We found that
these AID-dependent hypo- and hyper-DMCs were significantly
depleted in promoters of genes and enriched in introns and
intergenic areas (binomial test, p < 0.001) (Figure 3B). AID-dependent hypo- and hyper-DMCs were also depleted in CpG islands,
shores, and shelves and enriched in open sea (binomial test, p <
0.001) (Figure 3C). Since AID-dependent DNA demethylation
is thought to be carried out via deamination and subsequent
DNA repair, similar to SHM, we investigated whether AID-dependent DMCs were enriched in genes reported to be targets of
SHM in GCBs (Liu et al., 2008). Interestingly, AID-dependent
hypo-DMCs were enriched in SHM hotspot genes (binomial
test, p < 0.001) (Figure 3D). As SHM occurs at highly expressed
genes, we also tested if AID-dependent DMCs were enriched in
genes highly expressed in WT GCBs (fragments per kilobase of
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See also Figure S4.

transcript per million mapped reads > 20). We found no enrichment for hypo-DMCs (data not shown), suggesting that hypomethylation results from AID targeting specific genomic loci,
not simply as a consequence of open chromatin structure or
regions with high transcriptional activity. We also found enrichment of AID-dependent hypo-DMCs in AID-associated doublestranded DNA (dsDNA) breaks identified using high-throughput
genomic translocation sequencing (Meng et al., 2014) (Fisher’s
exact test, p < 0.001) (Figure 3D) and in loci associated with double-strand breaks defined through g-H2AX occupancy (Barlow
et al., 2013) (Fisher’s exact test, p < 0.001) (Figure 3D), suggesting
an association between AID-dependent hypomethylation and
DNA breaks.
The AID/APOBEC family of proteins has been known to contribute to intrinsic immunity against retrotransposition of endogenous and exogenous retroviruses (Goodier and Kazazian,

2008). Endogenous retroviruses are present in multiple copies
in mammalian genomes and constitute up to a staggering 8%
of human and mouse genomic DNA (gDNA) (Ryan, 2004; Stocking and Kozak, 2008). As AID-dependent DMCs are enriched
in introns and intergenic regions (Figure 3B), we investigated
whether AID targets repetitive elements present in those regions
of the genome. We annotated our AID-dependent DMCs according to RepeatMasker (see Experimental Procedures) and identified six intergenic repetitive elements that were significantly
enriched for the presence of AID-dependent DMCs, including
L1 repeat element, IAPEY3_LTR, and MLT1J1 (Figure S4A).
We also found two intragenic repetitive elements that were
significantly enriched to contain AID-dependent DMCs (Figure S4B). In summary, although we do find cases of enrichment
at specific repetitive elements, AID acts mostly upon non-repetitive DNA sequences.
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Epigenetic Hotspots and Effect on Gene Expression
We next investigated if, similar to SHM targets, there were hotspots of AID epigenetic activity in GCBs. In order to identify
such ‘‘epigenetic hotspots,’’ we looked for differentially methylated regions (DMRs) based on the presence of at least five
DMCs, a maximum distance of 250 kb between DMCs, and at
least 10% difference between average methylation within the
region. We identified 119 DMRs between NBs and GCBs from
WT mice, distributed throughout all chromosomes and consisting predominantly of hypo-DMRs (Figure 4A, left). We observed
that these DMRs were mostly AID dependent, and 88 hypoDMRs and 16 hyper-DMRs were lost in Aicda / animals (Figure 4A, right; Table S1), in agreement with our results from the
analysis of DMCs (Figure 1). We validated these findings using
the MassARRAY Epityper on several loci and on replicates of
WT and AID-deficient NBs and GCBs. Figure S5A shows that
the transition from NB to GCB in Aicda / mice is accompanied
by lower demethylation in AID-dependent DMRs compared to
WT mice. As a result, the percentage of methylation in Aicda /
GCBs is statistically higher than in WT GCBs although still lower
than in Aicda / NBs due to AID-independent demethylation
mechanisms (Figure S5A).
In order to understand the significance of AID-dependent
methylation changes, we evaluated the effect on gene expression in NB and GCB using RNA-seq data for all RefSeq genes.
We found that although there is a clear difference in expression
profiles according to cell type, there is no significant difference
in profiles according to AID genotype (Figures S5B and S5C).
However, we did identify several genes containing AID-dependent hypo-DMRs, including B cell-relevant genes (e.g., Cdk6,
Abcc4, and Fanca) and known targets of SHM (e.g., Pax5 and
Cd83), that exhibit small gene expression differences between
the respective genotypes (Figure 4B). These genes represent
epigenetic targets of AID, which may be deregulated not only
by SHM or translocations but also via changes in DNA methylation. We also analyzed the expression of genes that have
been implicated in DNA methylation (DNMTs, TETs, and IDHs)
and found no significant difference between WT and Aicda /
cells (data not shown). An unsupervised pathway analysis revealed that AID-dependent hypomethylated genes are involved
in pathways critical for B lymphocyte development, such as proliferation, B cell commitment, lymphocyte arrest of differentiation, and antibody response (Figures 4C and 4D). To assess
whether DMR-associated genes have decreased diversity of
expression in Aicda / GCBs, we calculated inter-sample pairwise correlation distances based on the expression of genes
associated with AID-dependent hypo-DMRs. We observed
that AID-dependent hypo-DMR-associated genes show a trend
toward decreased heterogeneity of expression in the Aicda /
GCBs compared to WT GCBs (Figure 4E). Even though this
change is not statistically significant, the potential biological
consequence of epigenetic diversification may be deregulated
gene expression and predisposition toward neoplastic transformation (Hansen et al., 2011).
We further explored the phenotypical consequences of the
AID-dependent DNA methylation diversity. We hypothesized
that if CpG methylation diversity was functional, it would not
be randomly distributed throughout the genome but rather asso-

ciated with specific gene expression patterns and specific gene
function. To address this, we investigated whether the GCB
methylome contained any hotspots for CpGs with high methylation variability. We defined ‘‘divergent CpG hotspots’’ as contiguous 1-kb regions enriched for divergent CpGs (methylation
interquartile range > 25% among replicates; Kemp et al., 2014)
using a hypergeometric mean distribution test. We found 6,952
divergent CpG hotspots in WT GCB replicates and only 788 hotspots in Aicda / GCBs (Figure S5D). We also observed that
96.7% (n = 6,725) of these divergent CpG hotspots were AID
dependent, as they were lost in the Aicda / animals (Figure S5D). Interestingly, AID-dependent divergent CpG hotspots
were located mostly in introns, distal regions, and intergenic
areas (Figure S5E), similarly to AID-dependent DMCs (Figure 3B).
A gene expression analysis revealed that Aicda / GCBs had
higher expression in genes overlapping divergent CpG hotspots
(n = 3,055) than WT GCBs (gene set enrichment analysis FDR q <
0.001; Figure S5F). Pathway analysis of these genes showed
enrichment in pathways regulating caspase activity and innate
and adaptive immune responses (Figure S5G).
To further elucidate the biological consequences of the AIDmediated epigenetic changes in the GCB genome, we investigated whether the methylome differences in WT and Aicda /
GCBs affected the proliferation and/or differentiation capacity
of these populations. We observed no differences in the cell-cycle distribution based on bromodeoxyuridine (BrdU) incorporation and 7-AAD staining of GCBs from WT and Aicda / mice
(Figure S5H). Although there was an increase in the percentage
of GCB in the Aicda / mice, we observed a reduction in the
NP-specific population, indicating a defect in the formation of
antigen-specific GCBs in the absence of AID (Figure S5I). We
also found that Aicda / GCBs presented lower expression of
the genes that are normally expressed upon terminal differentiation into plasma and memory cells when compared to WT GCBs
(Figure S5J). Even though the cause of such effect on plasmacytic differentiation in Aicda / mice is rooted in the absence
of AID-dependent affinity maturation, further investigation of
the contribution of DNA methylation to this process is warranted.
Conserved Epigenetic Function of AID between Human
and Mouse B Cells
To investigate whether the AID epigenetic program in mouse GC
was conserved in human GC, we sorted NBs (CD20+IgD+CD77 )
and GCBs (CD20+IgD CD77+) from reactive human tonsils (see
Experimental Procedures) and profiled their methylome using
ERRBS. Using the same criteria applied to mouse data to call
DMCs, we confirmed that human GCBs also underwent extensive hypomethylation compared to NBs and displayed greater
epigenetic diversity than NBs (Figures 5A and 5B). Although
we identified a greater number of DMCs in the human NB to
GCB transition (69,277 hypo-DMCs and 5,991 hyper-DMCs),
the genome-wide distribution of human DMCs was very similar
to the distribution of murine DMCs, with enrichment in introns
and depletion in CpG islands, CpG shores, and CpG shelves
(Figures 5C and 5D). To address whether the methylation
changes underlying the GC transition in human cells affected
the same AID-epigenetic targets, we characterized DMRs between human NBs and GCBs, applying the same criteria used
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Figure 4. AID Epigenetic Hotspots and Effect on Gene Expression
(A) Ideogram of DMRs in WT (left) and Aicda / (right) cells showing depletion of DMRs in Aicda / cells. Hypo-DMRs are indicated in blue, and hyper-DMRs are
indicated in yellow.
(B) Genes overlapping AID-dependent hypo-DMRs with >1.2-fold GCB/NB expression ratio between WT and Aicda / cells. Upregulated genes in Aicda / cells
are shown in red, and downregulated genes in Aicda / cells in are shown in blue.
(C) Pathway analysis (IPA) of the genes overlapping AID-dependent hypo-DMRs. The graph shows the name and the functional annotations of the genes with
hypo-DMRs in WT cells that are absent in Aicda / cells.
(D) Heatmap showing significance of enrichment of the pathways identified by IPA, using hypergeometric p values.
(E) Density plot showing expression correlation distance for genes overlapping AID-dependent hypo-DMRs between WT and Aicda / GCB replicates. Variability
of gene expression is lower in Aicda / GCBs.
See also Figure S5.
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Figure 5. Conserved Epigenetic Function of AID between Human and Mouse B Cells
(A) Combined CpG methylation values (top) and DMCs (bottom) between NBs and GCBs from human tonsils (four replicates) determined by ERRBS using a 20%
methylation difference threshold and FDR < 0.001 (Fisher’s exact test). Hypomethylated CpGs are indicated in blue, and hypermethylated CpGs are indicated in
yellow.
(B) Heatmap showing pairwise methylation distance between ERRBS profiles of NB and GCB replicates from human tonsils with GCBs showing greater intrasample methylation distance (green versus yellow).
(C) Bar plot showing genomic distribution of hypo-DMCs and hyper-DMCs as well as all CpGs represented within ERRBS experiments. DMCs show depletion in
promoters and enrichment in introns and distal and intergenic regions.

(legend continued on next page)
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in mouse samples, and assessed the significance of overlap
between orthologs of murine genes associated with AID-dependent DMRs and human genes associated with DMRs. Remarkably, we observed a significant overlap between murine
AID-dependent hypo-DMR-associated gene orthologs and human genes containing hypo-DMRs (p = 5.73e-08) (Figure 5E).
The comparability of epigenetic reprogramming between mouse
and human GC suggests that epigenetic changes associated
with the NB to GCB transition are conserved between species,
similar to conservation of the transcriptional programming.
DISCUSSION
In the present study, we have demonstrated using a genomewide approach that B cell transit through the GC is accompanied
by locus-specific hypomethylation and minor gains of methylation, along with a substantial increase in DNA methylation diversity. More importantly, our results indicate that such changes
are largely mediated by AID. In the last decade, we have gained
in-depth knowledge regarding the function of epigenetic alterations in normal development and cancer biology. DNA methylation is understood to play a key role in gene imprinting, X chromosome inactivation, and regulation of gene expression specific
to tissue identity, developmental stage, and cell lineage (Bird,
2002; Jones and Takai, 2001). Changes in the DNA methylome
mark specific stages of B cell ontogeny and play an important
role in B cell lymphomagenesis (De et al., 2013; Jeong et al.,
2014; Kulis et al., 2012; Lai et al., 2013; Mayle et al., 2014; Shaknovich et al., 2010; Zhang et al., 2014). The GC stage of B cell
development is associated with a proliferative burst, affinity
maturation of B cells with associated SHM and CSR, all of which
contribute to adaptive immune response and determine antibody diversity (Klein and Dalla-Favera, 2008), but the contribution of the methylome to these processes is not clearly defined.
Previously, we showed that changes in methylation are required
for the successful formation of the GC and that such modifications are dependent on DNMT1, a methyltransferase highly expressed in GCBs (Shaknovich et al., 2011). While the mechanism
of DNA methylation gain is well understood, the mechanism of
demethylation, the factors responsible for the loss of methylation
in GCBs, and its biological significance remain almost completely unknown. Since AID is highly expressed in GCBs and
has been implicated in DNA demethylation during embryonic
development and epigenetic reprogramming (Bhutani et al.,
2010; Kumar et al., 2013; Popp et al., 2010; Rai et al., 2008),
we hypothesized that AID is involved in the active demethylation
of B cells during GC transition.
To prove this hypothesis, we isolated NBs and GCBs from
in vivo WT and Aicda / mice and profiled their methylome using
ERRBS, a genome-wide approach capable of interrogating
three million CpGs. We observed that over 90% of methylome alterations characterizing the transition from NBs to GCBs were
lost in Aicda / animals, confirming the role of AID in the DNA

demethylation of the GCB genome. We also found that AID
depletion caused loss of hypermethylation in GCBs. We suspect
this to be a result of reduced recruitment of DNMT1 to doublestrand breaks (Ha et al., 2011), putatively generated as a consequence of the AID deamination activity (Zan and Casali, 2008).
Several prior attempts to link AID to demethylation in GCBs
were made before. Fritz et al. addressed this same question using an ex vivo system, activating primary splenocytes in the presence of anti-CD40, LPS, and IL-4 (Fritz et al., 2013). The authors
could not detect AID-induced changes in the B cell methylome,
consistent with our results with ex vivo stimulated B cells.
This suggests that AID-dependent demethylation is coupled to
the rate of SHM, which is much lower in the ex vivo system
than in GCBs (McKean et al., 1984; Robbiani et al., 2008). In
this regard, it has recently been demonstrated that ex vivo stimulated B cells are defective in SHM because the initiating form of
RNA polymerase II is not retained in the variable regions of
the Ig genes, hampering the recruitment of the cofactor Spt5
and AID (Maul et al., 2014). Another attempt to delineate the
demethylation function of AID in GCBs was made by Hogenbirk
et al. using MethylCap sequencing (MethylCap-seq) and failed to
find any AID-dependent changes (Hogenbirk et al., 2013). MethylCap-seq is an affinity-purification-based technique, which is
likely not to be sufficiently sensitive to detect variable methylation changes in CpGs scattered throughout genome. Here,
we have used ERRBS, a genome-wide technique with higher
coverage compared to MethylCap-seq and single-nucleotidelevel resolution (Rodriguez et al., 2012). We think that the above
differences are due to the experimental system and the techniques used in earlier studies. Confirmation of AID-dependent
changes that we identified using the MassARRAY Epityper validates ERRBS-based findings.
Importantly, we have demonstrated that the epigenetic diversification of the B cell methylome during GC transition is dependent on AID activity. It is tempting to speculate that this
methylation diversification may contribute, along with SHM, to
clonal evolution among normal GCBs. We show here that the
genomic distribution of hypo-DMRs in GCBs is similar to the distribution of AID binding sites revealed by Liu et al. (Liu et al.,
2008). We also provide circumstantial evidence that the demethylase function of AID may arise from its deaminase activity,
showing that AID-dependent hypo-DMCs are enriched within
known AID target genes for SHM. Despite expectation that
AID-dependent differential methylation would be concentrated
around transcription start sites (TSSs) of genes, similar to SHM
hotspots, our data reveal that DMCs are enriched in gene introns
and intergenic regions. This is consistent with the location of
AID-dependent demethylation observed in other systems (Kumar et al., 2013; Popp et al., 2010). We also found enrichment
of AID-dependent hypo-DMCs at loci associated with dsDNA
breaks. It is possible that, despite the intense focus on SHM
target genes, AID may bind genome-wide, with the majority of
binding similarly distributed outside of TSS and gene bodies.

(D) Bar plot showing distribution of hypo-DMCs and hyper-DMCs within CpG islands, shores, shelves, and open sea. DMCs are depleted within CpG islands and
shelves and enriched within CpG open sea.
(E) Heatmap showing significance of overlap between murine AID-dependent hypo-DMR-associated genes and human hypo-DMR-associated genes (*p < 0.05,
**p < 0.01, and ***p < 0.001).
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This would suggest AID deamination activity to have more farreaching consequences than we have yet appreciated. It has
been proposed that AID-dependent regions of demethylation
may extend beyond the deamination sites as a result of the
activity of processive DNA repair pathways (mismatch repair or
long-patch base excision repair). These pathways can result in
the replacement of long stretches of DNA (up to 2 kb) with
concomitant possible repair of all somatic mutations (Franchini
et al., 2014). Such broad extension of hypomethylation could,
in turn, have various consequences, including instability of
transposable elements, chromosomal translocations, and gene
deregulation, as suggested by the Jaenisch’s group (Gaudet
et al., 2003).
In the present study, we were able to detect subtle effects of
AID on genes associated with AID-dependent DMRs, including
greater variability of gene expression of these epigenetic targets
and at the same time consistent changes in a handful of epigenetic hotspots that include genes also targeted by SHM, such
as Pax5 and Cd83. The up- and downregulation of gene expression between WT and Aicda / cells may be explained by the
DMR location in relation to the TSS, since promoter versus
gene body methylation may have opposite effects on gene
expression (Jaenisch and Bird, 2003), or it may be a secondary
effect of a permissive environment for gene regulation through
binding of transcription factors or through histone modifications.
There is a significant effect on expression in genes overlapping
divergent CpG hotspots—loci with high methylation variability—indicating that AID-dependent methylation diversity is
not random and affects specific functions. There is also a detectable statistically significant hypomethylation of repetitive elements, with still uncertain consequences to be investigated in
future work.
Although AID loss abrogates the majority of the methylation
changes experienced by GCB, we observe residual hypomethylation in Aicda / GCBs, suggesting that other demethylation
mechanisms are likely to exist in these cells. The most plausible
scenario is TET-dependent oxidative demethylation, which has
been proposed as an alternative to AID deamination-dependent
demethylation (Kohli and Zhang, 2013). Another source of
demethylation may be passive loss of methylation in highly proliferative GCBs. The fact that Aicda / GCBs are hyperplastic
and highly proliferative, and nevertheless have minimal loss of
methylation, argues against this theory. Moreover, passive stochastic loss of methylation would likely be randomly distributed
throughout the genome, and our results show preferential genomic distribution of the methylation changes. All mechanisms
will need more formal examination before the final model of
DNA demethylation in GCBs is formulated, but our results indicate for the fist time a clear epigenetic role for AID in B cell maturation during GC transition.
EXPERIMENTAL PROCEDURES
Mouse and Human B Cell Isolation
Aicda / mice were a generous gift from T. Honjo. WT (BALB/c) mice were
from The Jackson Laboratory. All animals were maintained according to the
guidelines of the Research Animal Resource Center of the Weill Cornell Medical College, which approved all mouse procedures. 10- to 12-week-old WT or
Aicda / mice were immunized intraperitoneally with NP-CGG ratio 20-25

(Biosearch Technologies) in alum (1:1) to induce GC formation. Mice were
sacrificed at day 10 after immunization, spleens were dissected, and mononuclear cells were purified using Histopaque (Sigma) gradient centrifugation.
Cell suspensions were enriched in B cells by positive selection with antiB220 magnetic microbeads (Miltenyi Biotech). B cells were separated in
NB (B220+GL7 FAS DAPI ) and GCB (B220+GL7+FAS+DAPI ) using a BD
FACSAria II sorter.
Leftover human tonsils were obtained after routine tonsillectomies, performed at New York Presbyterian Hospital. All tissue collection was approved
by the Weill Cornell Medical College Institutional Review Board. Tonsils were
minced and mononuclear cells were isolated using Histopaque density centrifugation. NBs were separated by positive selection using the AUTOMACS system (Miltenyi Biotech) after incubation with anti-IgD fluorescein isothiocyanate
(FITC) (BD Pharmingen) followed by anti-FITC microbeads (Miltenyi Biotec).
GCBs were separated by positive selection with anti-CD77 (AbD Serotec) followed by mouse anti-IgM, IgG1 isotype (BD Pharmingen), and anti-mouseIgG1 microbeads (Miltenyi Biotec).
Ex Vivo Activated B Cell Cultures
Activation of B cells and infection with EV or AID-expressing vector was performed as described in Supplemental Experimental Procedures.
Flow Cytometry Analysis and Antibodies
Flow cytometry analysis of mouse NBs and GCBs was performed using the
following fluorescent-labeled anti-mouse antibodies: APC-conjugated antiB220 (BD Pharmingen), PE-Cy7-conjugated anti-CD95 (BD Pharmingen),
FITC-conjugated anti-GL7 (BD Pharmingen), and PE-conjugated CXCR4
(eBioscience). Cell-cycle analysis was performed using the BrdU Flow Kit
(BD Pharmingen), and antigen-specific GCBs (NP+GL7+CD95+B220+) were
detected using PE-conjugated NP (Biosearch Technologies). Ex vivo stimulated B cells were stained with PE-Cy7-conjugated anti-B220 (eBioscience),
PE-conjugated anti-IgD (BD Pharmingen), and APC-conjugated anti-IgG1
(BD Pharmingen). DAPI was used for the exclusion of dead cells. Data were acquired on a MACSQuant analyzer (Miltenyi Biotec) and analyzed using FlowJo
7.6.4 software (Tree Star).
ERRBS
50 ng gDNA was bisulfite converted using the EZ DNA Methylation kit (Zymo
Research). Base-pair-resolution DNA methylation analysis was performed in
WT mice (n = 7, 3 males 4 females) and Aicda / mice (n = 6, 3 males and 3
females) following the ERRBS protocol previously described (Akalin et al.,
2012). DMCs were identified by using a 20% methylation difference
threshold and a Benjamini-Hochberg-adjusted Fisher’s exact test p value <
0.001 on sum of all methylated and unmethyated CpGs among replicate
samples. Delta methylation was calculated by subtracting the combined
NB methylation percent from the combined GCB methylation percent.
DMRs were detected using RRBSseeqer with parameters of 250 bp maximum distance between DMCs, minimum of five DMCs per region, and
10% total methylation difference for region. Ideogram was generated using
the ggbio package (Yin et al., 2012) and UCSC GRCm38 CytoBand data
from the RCircos package (Zhang et al., 2013). Epigenetic diversity and
diverse CpG hotspots were calculated as described in Supplemental Experimental Procedures.
Single-Locus DNA Methylation Assays
EpiTYPER assays were performed on bisulfite-converted gDNA. For the biologic validation of the AID-dependent hypo-DMRs in mouse B cells, primers
were designed to cover CpG islands associated with the respective DMRs.
All primers were designed using Sequenom EpiDesigner BETA software
(http://www.epidesigner.com/). Primer sequences are shown in Supplemental
Experimental Procedures.
Mass-Array-Based Variance Comparisons
We performed three pairwise comparisons of methylation variances: (1)
AID_KO_NB versus AID_KO_GCB, (2) AID_WT_GCB versus AID_KO_GCB,
and (3) AID_WT_NB versus AID_WT_GCB. For each pairwise comparison,
we calculated the sample variances in each of the two groups across all
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Cytosine Methylation Mass Spectrometry
1 mg genomic DNA was denatured by heating at 100 C. 5 U Nuclease P1
(Sigma) was added, and the mixture was incubated at 37 C for 2 hr. A 1/10 volume of 1 M ammonium bicarbonate and 0.002 U venom phosphodiesterase 1
(Sigma) was added to the mixture and the incubation continued for 2 hr at
37 C. Then, 0.5 U alkaline phosphatase (Roche) was added and the mixture
was incubated for 1 hr at 37 C. Quantification was done using an LC-ESIMS/MS system (Agilent 1200 Series liquid chromatography machine in tandem with the Agilent 6410 Triple Quad Mass Spectrometer) in multiple reaction
monitoring (MRM) mode as described previously (Song et al., 2005). Chromatographic separation was performed at a flow rate of 220 l/min.
V(D)J Rearrangement Analysis
Ig rearrangement analysis was performed on gDNA of mouse WT GCB (n = 3)
and Aicda / mice GCB (n = 4), amplifying IgH, Igk, and Igl regions by PCR.
Primers annealed to the framework region of the most abundant families of
Ig rearrangements, as described previously (Chang et al., 1992; Cobaleda
et al., 2007; Schlissel et al., 1991). Primer sequences have been described previously (Hanna et al., 2008). Ig rearrangement analysis was performed as
described in Supplemental Experimental Procedures.
RNA-Seq
RNA-seq was carried out as described in Supplemental Experimental
Procedures.
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